STOCK TITAN

[6-K] ORIX CORP Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

ORIX Corporation reports a restricted-share issuance under an employee plan with a disposal price of ¥3,882 per share and a total contribution of ¥552,796,800. The filing states the paid-in amount from the contributions will not be incorporated into capital. The document lists two participant counts as "234 Persons" and "84 Persons" and describes the consideration as in-kind contributions of the Monetary Grant held by Eligible Employees, which will be provided by the company or its subsidiaries for the Restricted Shares. The filing provides basic transaction values and participant counts but does not include further detail on allocation, vesting, or impact on outstanding share count.

ORIX Corporation segnala un'emissione di azioni ristretta nell'ambito di un piano per i dipendenti con un prezzo di disposizione di 3.882¥ per azione e un contributo totale di 552.796.800 ¥. La pratica indica che l'importo versato dai contributi non sarà incorporato nel capitale. Il documento elenca due conteggi di partecipanti come '234 persone' e '84 persone' e descrive la controprestazione come contributi in natura del Sussidio Monetario detenuto dai dipendenti idonei, che saranno forniti dall'azienda o dalle sue filiali per le azioni ristrette. Il file fornisce valori di transazione di base e conteggi dei partecipanti ma non include ulteriori dettagli sull'allocazione, la vesting o l'impatto sul flottante azionario.
ORIX Corporation informa de una emisión de acciones restringidas bajo un plan para empleados con un precio de disposición de ¥3,882 por acción y una contribución total de ¥552,796,800. La presentación indica que la cantidad pagada de las contribuciones no se incorporará al capital. El documento enumera dos recuentos de participantes como '234 personas' y '84 personas' y describe la contrapartida como aportaciones en especie del Subsidio Monetario mantenido por los Empleados Elegibles, que serán proporcionadas por la empresa o sus subsidiarias para las Acciones Restringidas. La presentación ofrece valores básicos de la transacción y recuentos de participantes, pero no incluye más detalles sobre asignación, vesting o impacto en el número de acciones en circulación.
ORIX Corporation은 직원 계획에 따른 제약 주식 발행을 보고하며 주당 처분가 3,882엔총 출자금 552,796,800엔를 제시합니다. 제출서에 따르면 출자금으로 납입된 금액 자본으로 편입되지 않을 예정이라고 명시되어 있습니다. 문서는 참여자 수를 ‘234명’과 ‘84명’으로 기재하고 보상은 자격을 갖춘 직원이 보유한 금융지원의 현물출자로서, 이는 제약 주식을 위해 회사 또는 자회사가 제공할 것이라고 설명합니다. 제출서는 기본 거래 가치와 참여자 수를 제공합니다만, 배분, 베스팅 또는 미발행 주식수에 미치는 영향에 관한 추가 세부 정보는 포함하지 않습니다.
ORIX Corporation signale une émission d’actions restreintes dans le cadre d’un plan pour les employés, avec un prix de cession de 3 882 ¥ par action et une contribution totale de 552 796 800 ¥. Le dossier indique que le montant versé au titre des contributions ne sera pas incorporé dans le capital. Le document répertorie deux nombres de participants, « 234 personnes » et « 84 personnes », et décrit la contrepartie comme des apports en nature du Subvention Monétaire détenu par les employés éligibles, qui seront fournis par l’entreprise ou ses filiales pour les actions restreintes. Le dossier donne des valeurs de transaction de base et des chiffres de participants mais ne comprend pas de détails supplémentaires sur l’allocation, l’acquisition (vesting) ou l’impact sur le nombre d’actions en circulation.
Die ORIX Corporation meldet eine Ausgabe restriktiver Aktien im Rahmen eines Mitarbeitendenplans mit einem Veräußerungspreis von 3.882 ¥ pro Aktie und einem Gesamtbeitrag von 552.796.800 ¥. Die Einreichung gibt an, dass der von den Beiträgen gezahlte Betrag nicht in Kapital eingezogen wird. Das Dokument listet zwei Teilnehmerzahlen als „234 Personen“ und „84 Personen“ auf und beschreibt die Gegenleistung als Sachleistungen aus dem Geldbeitrag der berechtigten Mitarbeitenden, die vom Unternehmen oder dessen Tochtergesellschaften für die Restricted Shares bereitgestellt werden. Die Einreichung liefert grundlegende Transaktionswerte und Teilnehmerzahlen, enthält jedoch keine weiteren Details zu Zuweisung, Vesting oder Auswirkungen auf die umlaufenden Aktien.
تُبلغ شركة ORIX باصدَار أسهم مقيدة بموجب خطة للموظفين بسعر عرض قدره 3 882 ين للسهم وبـ مساهمة كلية قدرها 552,796,800 ين. ينص الملف أن المبلغ المدفوع من المساهمات لن يُدمَج في رأس المال. يسجل المستند عددين للمشاركين كـ «234 شخصًا» و«84 شخصًا» ويصف المقابل بأنه مساهمات عينية من المنحة النقدية التي يحتفظ بها الموظفون المؤهلون، والتي ستوفرها الشركة أو فروعها للأسهم المقيدة. يوفر الملف قيم معاملات أساسية وعدد مشاركين، لكن لا يتضمن تفاصيل إضافية حول التخصيص، وVest­ing، أو تأثيره على عدد الأسهم القائمة.
ORIX Corporation 报告在员工计划下发行受限股,发行价格为每股 ¥3,882,总出资额为 ¥552,796,800。申报中指出,来自出资的实缴金额 不计入资本。该文件将参与者人数列为“234人”和“84人”,并将对价描述为 由符合条件的员工持有的货币补助的实物出资,由公司或其子公司为受限股提供。申报提供了基本的交易价值和参与者人数,但未包含关于分配、归属或对在外流通股数影响的进一步细节。
Positive
  • Clear monetary disclosure: Total contribution amount of ¥552,796,800 is stated.
  • Stated per-share price: Disposal price specified at ¥3,882 per share.
Negative
  • Paid-in amount not incorporated into capital: The filing explicitly states contributions will not be added to capital, which affects equity accounting.
  • Insufficient participant detail: The roles of the listed "234 Persons" and "84 Persons" are not explained, and vesting/allocation details are missing.

Insights

TL;DR: ORIX documents a ¥552.8M restricted-share consideration at ¥3,882 per share; this appears to be an employee compensation issuance with limited disclosure.

The filing supplies clear dollar amounts and per-share price, enabling straightforward calculation of shares involved (total contribution divided by disposal price). However, key investor metrics are missing: the exact number of shares issued, vesting terms, dilution impact, and whether these shares are newly issued or reallocated from treasury. Without those details, assessing EPS or ownership dilution impact is not possible from this filing alone.

TL;DR: Disclosure indicates an employee equity award mechanism but omits governance and plan specifics that investors typically expect.

The document confirms the mechanism (monetary grants converted to restricted shares) and the aggregate monetary amount, which is useful for governance review. It also specifically states paid-in amounts will not increase stated capital, a technical detail relevant to equity accounting. The filing does not include participant eligibility criteria, vesting schedules, or board approvals referenced, limiting assessment of alignment with shareholder interests.

ORIX Corporation segnala un'emissione di azioni ristretta nell'ambito di un piano per i dipendenti con un prezzo di disposizione di 3.882¥ per azione e un contributo totale di 552.796.800 ¥. La pratica indica che l'importo versato dai contributi non sarà incorporato nel capitale. Il documento elenca due conteggi di partecipanti come '234 persone' e '84 persone' e descrive la controprestazione come contributi in natura del Sussidio Monetario detenuto dai dipendenti idonei, che saranno forniti dall'azienda o dalle sue filiali per le azioni ristrette. Il file fornisce valori di transazione di base e conteggi dei partecipanti ma non include ulteriori dettagli sull'allocazione, la vesting o l'impatto sul flottante azionario.
ORIX Corporation informa de una emisión de acciones restringidas bajo un plan para empleados con un precio de disposición de ¥3,882 por acción y una contribución total de ¥552,796,800. La presentación indica que la cantidad pagada de las contribuciones no se incorporará al capital. El documento enumera dos recuentos de participantes como '234 personas' y '84 personas' y describe la contrapartida como aportaciones en especie del Subsidio Monetario mantenido por los Empleados Elegibles, que serán proporcionadas por la empresa o sus subsidiarias para las Acciones Restringidas. La presentación ofrece valores básicos de la transacción y recuentos de participantes, pero no incluye más detalles sobre asignación, vesting o impacto en el número de acciones en circulación.
ORIX Corporation은 직원 계획에 따른 제약 주식 발행을 보고하며 주당 처분가 3,882엔총 출자금 552,796,800엔를 제시합니다. 제출서에 따르면 출자금으로 납입된 금액 자본으로 편입되지 않을 예정이라고 명시되어 있습니다. 문서는 참여자 수를 ‘234명’과 ‘84명’으로 기재하고 보상은 자격을 갖춘 직원이 보유한 금융지원의 현물출자로서, 이는 제약 주식을 위해 회사 또는 자회사가 제공할 것이라고 설명합니다. 제출서는 기본 거래 가치와 참여자 수를 제공합니다만, 배분, 베스팅 또는 미발행 주식수에 미치는 영향에 관한 추가 세부 정보는 포함하지 않습니다.
ORIX Corporation signale une émission d’actions restreintes dans le cadre d’un plan pour les employés, avec un prix de cession de 3 882 ¥ par action et une contribution totale de 552 796 800 ¥. Le dossier indique que le montant versé au titre des contributions ne sera pas incorporé dans le capital. Le document répertorie deux nombres de participants, « 234 personnes » et « 84 personnes », et décrit la contrepartie comme des apports en nature du Subvention Monétaire détenu par les employés éligibles, qui seront fournis par l’entreprise ou ses filiales pour les actions restreintes. Le dossier donne des valeurs de transaction de base et des chiffres de participants mais ne comprend pas de détails supplémentaires sur l’allocation, l’acquisition (vesting) ou l’impact sur le nombre d’actions en circulation.
Die ORIX Corporation meldet eine Ausgabe restriktiver Aktien im Rahmen eines Mitarbeitendenplans mit einem Veräußerungspreis von 3.882 ¥ pro Aktie und einem Gesamtbeitrag von 552.796.800 ¥. Die Einreichung gibt an, dass der von den Beiträgen gezahlte Betrag nicht in Kapital eingezogen wird. Das Dokument listet zwei Teilnehmerzahlen als „234 Personen“ und „84 Personen“ auf und beschreibt die Gegenleistung als Sachleistungen aus dem Geldbeitrag der berechtigten Mitarbeitenden, die vom Unternehmen oder dessen Tochtergesellschaften für die Restricted Shares bereitgestellt werden. Die Einreichung liefert grundlegende Transaktionswerte und Teilnehmerzahlen, enthält jedoch keine weiteren Details zu Zuweisung, Vesting oder Auswirkungen auf die umlaufenden Aktien.
 
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-14856

 

  

 

ORIX Corporation

(Translation of Registrant’s Name into English)

 

 

World Trade Center Bldg., SOUTH TOWER, 2-4-1 Hamamatsu-cho, Minato-ku, Tokyo, JAPAN

(Address of Principal Executive Offices)

 

 

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F ☒     Form 40-F ☐

 

 
 


Table of Contents

Material Contained in this Report

 

1.

Announcement Regarding Disposal of Own Shares as Restricted Stock


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    ORIX Corporation
Date: October 1, 2025     By  

/s/ Yasuaki Mikami

      Yasuaki Mikami
     

Member of the Board of Directors

Senior Managing Executive Officer

Responsible for Corporate Function Unit

Responsible for Work Style Reform Project

ORIX Corporation


Announcement Regarding Disposal of Own Shares as Restricted Stock

TOKYO, Japan — October 1, 2025 (U.S. time) — ORIX Corporation (the “Company”) (TSE: 8591; NYSE: IX), a leading integrated financial services group, announced today that it filed an extraordinary report with the Director-General of the Kanto Financial Bureau in Japan concerning the disposal of its own shares (the “Disposal”).

 

1

Reason for Filing

On October 1, 2025, the Company’s Representative Executive Officer resolved to dispose of its own shares (the “Allotted Shares”) to employees of the Company and its subsidiaries (the “Eligible Employees”) under the Restricted Share Grant Plan (the “Plan”), pursuant to the delegation authorized by the resolution of the Board of Directors held on June 25, 2025, in accordance with Article 416, Paragraph 4 of the Companies Act of Japan.

Accordingly, this Extraordinary Report is hereby submitted pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item (ii)-2 of the Cabinet Office Ordinance on Disclosure of Corporate Affairs.

 

2

Description of Report

 

(1)

Outline of Disposal

 

     

 

Stock name

 

  

 

Class

 

 

 

Details of the shares

 

     

 

ORIX Corporation  shares

 

  

 

Common 

stock

 

 

 

These shares are standard common stock of the Company with full voting rights and no restrictions on shareholder rights. The number of shares per unit is 100.

 

 

         
Number of shares to
be disposed
   Disposal price    Total value of
shares to be
disposed
   Amount
incorporated into
capital
   Total amount
incorporated into
capital
         
142,400 shares     3,882 Yen     552,796,800 Yen     —     — 

*The Disposal price represents the paid-in amount under the Companies Act of Japan in connection with the Disposal of its own shares, and the total disposal value corresponds to the aggregate paid-in amount under the Companies Act for the Disposal.

It should be noted that, as the offering covered by this Extraordinary Report is conducted through the disposal of its own shares, the paid-in amount will not be incorporated into capital.

 

(2)

Number and breakdown of offerees for the solicitation of acquisition or sale

 

     
Offerees   

Number of the 

offerees 

   Number of
shares to be
disposed
     
Employees of the Company    234 Persons     106,400 shares 
     
Employees of the Company subsidiaries    84 Persons     36,000 shares 

*The term “subsidiary” refers to a subsidiary as defined in Article 8, Paragraph 3 of the Regulation on Terminology, Forms, and Preparation Methods of Financial Statements. The same applies hereinafter.

 

- 1 -


(3)

Relationship between the filing company and its subsidiary when the offeree is a director, etc. of the subsidiary (as defined in article 2, paragraph 12, item 1 of the cabinet order for enforcement of the financial instruments and exchange act)

Subsidiaries that are either wholly owned by the Company or in which the Company holds a majority of voting rights on its own account.

 

(4)

Content of the agreement between the filing company and the offeree

The Company plans to enter into a Restricted Share Allotment Agreement with the Eligible Employees, which will include, in essence, the following terms. Accordingly, the shares of common stock of the Company subject to this Extraordinary Report are expected to fall under “Specified Restricted Shares” as defined in Article 54, Paragraph 1 of the Corporation Tax Act and Article 84, Paragraph 1 of the Cabinet Order for Enforcement of the Income Tax Act.

This Disposal will be conducted through in-kind contributions of the Monetary Grant held by the Eligible Employees, which will be provided by the Company or its subsidiaries as consideration for the Restricted Shares under the Plan. The total amount of the monetary claims to be contributed is 552,796,800yen, with 3,882yen per share to be allocated as the contribution value.

1. Transfer Restriction Period

From December 1, 2025 to November 30, 2028

2. Conditions to Lift Transfer Restrictions

If an Eligible Employee continues to serve as an employee of the Company or the Company’s subsidiaries in positions determined by the Company to be eligible (the “Eligible Position”) throughout the Transfer Restriction Period, the transfer restrictions will be lifted for all of the Eligible Employee’s Allotted Shares at the end of the Transfer Restriction Period.

However, if the Eligible Employee loses such Eligible Position due to reaching retirement age or in such other circumstances as the Company may deem justifiable, then the transfer restrictions shall be lifted for all of the Allotted Shares on the first day of June or December (whichever comes first) following the day such circumstances occur.

3. Acquisition by the Company without consideration

If certain events occur during the Transfer Restriction Period, such as the Eligible Employee’s loss of their Eligible Position due to reasons other than those stipulated in 2 above, the Company can acquire all of the Allotted Shares held by the Eligible Employee at that point in time without consideration.

In addition, the Company can acquire without consideration all of the Allotted Shares held by the Eligible Employee at the time immediately following the expiration of the Transfer Restriction Period if the Transfer Restrictions have not been lifted at that time.

4. Treatment in the event of organizational restructuring, etc.

If, during the Transfer Restriction Period, a merger agreement under which the Company will become a defunct company, a share exchange agreement under which the Company will become a wholly owned subsidiary, a share transfer plan, or any other matters relating to organizational restructuring, etc. are approved at a general meeting of the shareholders of the Company (however, if approval by a general meeting of the shareholders of the Company is not required for such organizational restructuring, then such matters requiring the approval of the Board of Directors of the Company) (an “Organizational Restructuring Event”), the Company may, at the Company’s discretion, lift the transfer restrictions on the Allotted Shares on the business day immediately prior to the effective date of such an Organizational Restructuring Event. Further, immediately prior to the effective date of such an Organizational Restructuring Event, the Company can acquire without consideration, all of the Allotted Shares held by the Eligible Employee of which the transfer restrictions have not been lifted as of that effective date.

 

- 2 -


(5)

Method of managing the relevant share certificates separately from other share certificates not subject to transfer restrictions

The Allotted Shares will be managed in a dedicated account opened by the Eligible Employee at Nomura Securities Co., Ltd. during the Transfer Restriction Period so that the Allotted Shares may not be transferred, pledged as collateral or otherwise disposed of during the Transfer Restriction Period. Even if a request is made by the Eligible Employee, the Allotted Shares managed in the dedicated account will be subject to restrictions on transfer or other disposition, and will be segregated from other shares of the Company that are not subject to transfer restrictions. In order to ensure the effectiveness of the transfer restrictions of the Allotted Shares, the Company has entered into an agreement with Nomura Securities Co., Ltd. to manage the Allotted Shares account held by each Eligible Employee, and the Eligible Employee agrees to the details of this management arrangement.

 

(6)

Payment date for the Allotted Shares

December 1, 2025

 

(7)

Name and address of the transfer institution

Name: Japan Securities Depository Center, Incorporated

Address: 7-1 Nihonbashi Kabutocho, Chuo-ku, Tokyo 103-0026, Japan

 

- 3 -

FAQ

What is the per-share disposal price in the ORIX (IX) filing?

The per-share disposal price is ¥3,882.

How much total monetary contribution is disclosed in the ORIX (IX) report?

The total contribution amount disclosed is ¥552,796,800.

Will the paid-in amount from the contributions be incorporated into ORIX's capital?

No. The filing states the paid-in amount will not be incorporated into capital.

How many participants are listed in the filing for the restricted-share plan (ORIX, IX)?

The document lists "234 Persons" and "84 Persons" but does not define these categories.

What form of consideration is being provided for the restricted shares in the ORIX (IX) filing?

In-kind contributions of the Monetary Grant held by Eligible Employees, provided by the company or its subsidiaries, are stated as the consideration.
Orix

NYSE:IX

IX Rankings

IX Latest News

IX Latest SEC Filings

IX Stock Data

28.46B
1.13B
2.32%
0.06%
Financial Conglomerates
Financial Services
Link
Japan
Tokyo